Physician profile
Sarah E Conerly
NPI 1396057139
$903.04
in general payments reported to CMS, 2019-2025
18 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2021: $30.64 · 2022: $52.97 · 2023: $151 · 2024: $104 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $219.58 | 2019-2023 | Fintepla |
| Livanova USA, INC. | $117.97 | 2019 | |
| Eisai INC. | $93.90 | 2019 | |
| Jazz Pharmaceuticals INC. | $68.15 | 2022-2025 | |
| Sk Life Science, INC. | $66.83 | 2025 | |
| Piramal Critical Care | $48.51 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $40.86 | 2019 | |
| Sunovion Pharmaceuticals INC. | $32.94 | 2019 | |
| Immedica Pharma US, INC. | $29.68 | 2024 | |
| Pyros Pharmaceuticals, INC. | $28.95 | 2024 | Vigpoder |
| Mallinckrodt Enterprises LLC | $24.27 | 2019 | |
| Orchard Therapeutics North America | $23.24 | 2025 | Lenmeldy |
| Zimmer Biomet Holdings, INC. | $22.97 | 2024 | Rosa |
| Acadia Pharmaceuticals INC | $20.45 | 2023 | Daybue |
| Biogen, INC. | $19.89 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $19.63 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $13.23 | 2023 | Fycompa |
| Novartis Pharmaceuticals Corporation | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Conerly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.